• 4 June, 2013
  • 6/4/2013 5:00:00 AM

    The International Society for Stem Cell Research (ISSCR) is excited to announce the inaugural issue of Stem Cell Reports, the society’s new open-access journal, published today. Stem Cell Reports, published for the ISSCR by Cell Press, presents high-quality, peer-reviewed research presenting conceptual or practical advances across the breadth of stem cell research and its applications to medicine, with a focus on shorter, single-point articles.
    Full story
  • 22 April, 2013
  • The ISSCR urges Italian lawmakers to heed concerns of scientists around the world about the premature practice of unproven stem cell treatments and to recognize the importance of regulatory oversight and patient protection when developing new stem cell medicines.
    Full story
  • 9 April, 2013
  • The International Society for Stem Cell Research (ISSCR) voices concern as the Italian government authorizes an unproven stem cell therapy for use in patients.
    Full story
  • 20 February, 2013
  • ISSCR President, Shinya Yamanaka, Board of Directors member Hans Clevers and the ISSCR 2013 Annual Meeting Keynote Speaker Eric Lander, were three of 11 distinguished recipients of the inaugural Breakthrough Prize in Life Sciences, announced today
    Full story
  • ISSCR Statement on U.S. Supreme Court decision to deny certiorari in case of Sherley v. Sebelius

  • 7 January, 2013
  • The International Society for Stem Cell Research (ISSCR) welcomes the decision of the US Supreme Court to deny certiorari in the case of Sherley v Sebelius, which had challenged federal funding of human embryonic stem cell research.
    Full story
  • ISSCR to Launch Open Access Journal, Stem Cell Reports

  • 24 October, 2012
  • The International Society for Stem Cell Research (ISSCR) announces the launch of Stem Cell Reports, its new online, open-access journal. With a focus on shorter, single-point articles, Stem Cell Reports will publish high-quality, peer-reviewed research presenting conceptual or practical advances across the breadth of stem cell research and its applications to medicine.
    Full story
  • ISSCR Reaffirms Support for All Forms of Stem Cell Research

  • 11 October, 2012
  • The ISSCR further congratulates Drs. Shinya Yamanaka and John Gurdon for their scientific achievements recognized by this year's Nobel Prize and reaffirms support for all forms of stem cell research.
    Full story
  • ISSCR Statement on Court Decision Upholding a Dismissal of Challenges to Federal Funding of Human Embryonic Stem Cell Research

  • 30 August, 2012
  • The International Society for Stem Cell Research (ISSCR) welcomes the finding of the U.S. Court of Appeals for the District of Columbia upholding an earlier dismissal of Sherley v Sebelius, a court case that had challenged federal funding of human embryonic stem cell research.
    Full story
  • The ISSCR Selects Yokohama, Japan, for its 10th Annual Meeting; First in Asia

  • 10 May, 2012
  • 5/10/2012 5:00:00 AM

    The ISSCR will hold its 10th annual meeting June 13-16, 2012, in Yokohama, Japan, at the PACIFICO Yokohama.
    Full story
  • ISSCR Emphasizes Rigorous Oversight for Application of Stem Cell-Based Treatments

  • 12 April, 2012
  • The ISSCR is concerned that some stem cell treatments are being prematurely offered to patients without safeguards in place to ensure safety and efficacy.
    Full story
  • ISSCR Honors Stem Cell Research Pioneer with Prestigious McEwen Award for Innovation

  • 23 February, 2012
  • The ISSCR is pleased to announce the winner of the 2012 McEwen Award for Innovation, a coveted prize in the field of stem cell research and regenerative medicine. The 2012 recipient is Rudolf Jaenisch, MD, Founding Member of the Whitehead Institute for Biomedical Research and Professor of Biology at the Massachusetts Institute of Technology
    Full story
  • ISSCR Statement on Recent Somatic Cell Nuclear Transfer (SCNT) Breakthrough: An Important Step Forward

  • 5 October, 2011
  • The International Society for Stem Cell Research (ISSCR) welcomes today’s announcement of an advance in stem cell science and reprogramming through somatic cell nuclear transfer or SCNT.
    Full story
  • ISSCR Statement on U.S. Court Decision to Dismiss Challenges to Federal Funding of Human Embryonic Stem Cell Research

  • 27 July, 2011
  • 7/27/2011 5:00:00 AM

    The ISSCR applauds the decision announced today by the U.S. District Court for the District of Columbia in the case of Sherley v. Sebelius, dismissing challenges to the U.S. National Institutes of Health’s (NIH’s) funding of human embryonic stem cell research.
    Full story
  • ISSCR Statement on Advocate General Opinion in Case C-34/10, Brüstle v Greenpeace eV

  • 12 April, 2011
  • The ISSCR reiterates its statement of April below in support of hESC research and policies that promote the responsible development of new therapies.
    Full story
  • ISSCR Decries Negative Impact of Stem Cell Injunction on Science and Medicine

  • 12 September, 2010
  • Vital progress in stem cell research by hundreds of U.S. laboratories is threatened after last week’s injunction prohibiting federal funding for the study of human embryonic stem cells (hESCs).
    Full story
  • ISSCR Launches Web Site Providing Information on Stem Cell Treatments

  • 8 June, 2010
  • The ISSCR announced today that it has launched "A Closer Look at Stem Cell Treatments" (www.closerlookatstemcells.org), a Web site to arm patients, their families and doctors with information they need to make decisions about stem cell treatments
    Full story
  • Stem Cell Society Leaders Receive Nation's Top Science Awards

  • 23 September, 2009
  • 9/23/2009 5:00:00 AM

    The ISSCR congratulates two board members who were named recipients of two of the nation’s top science awards, Shinya Yamanaka, MD, PhD (Kyoto University), and Elaine Fuchs, PhD (Rockefeller University).
    Full story
  • Tumors After Attempted Stem Cell Therapy Highlight Importance of Rigorous Standards Before Clinical Treatment

  • 4 March, 2009
  • 3/4/2009 6:00:00 AM

    The ISSCR is concerned and saddened by the recent report of nervous system tumors that developed in a child who had previously received injections of cell preparations referred to as “neural stem cells.” This illustrates the concerns that prompted the ISSCR to develop Guidelines for the Clinical Translation of Stem Cells, released in December 2008.
    Full story
  • Scientists See Progress in FDA Stem Cell Trial Approval

  • 6 January, 2009
  • 1/6/2009 6:00:00 AM

    The ISSCR shares in the excitement generated by the U.S. Food and Drug Administration‘s landmark decision to approve the first clinical trials using the products of human embryonic stem cells, yet advises the public to maintain realistic expectations at this early stage.
    Full story
  • The ISSCR Releases New Guidelines to Shape Future of Stem Cell Therapy

  • 3 December, 2008
  • The ISSCR releases Guidelines for the Clinical Translation of Stem Cells, defining a roadmap for medical researchers and doctors, outlining what needs to be accomplished to move stem cells from promising research to proven treatments for patients
    Full story
    View All ISSCR News